Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Research & Development (2023)

Stemtech's Research & Development history spans 1 years, with the latest figure at $177.0 for Q2 2023.

  • On a quarterly basis, Research & Development changed N/A to $177.0 in Q2 2023 year-over-year; TTM through Mar 2024 was $177.0, a 98.72% decrease, with the full-year FY2023 number at $13800.0, changed N/A from a year prior.
  • Research & Development hit $177.0 in Q2 2023 for Stemtech, down from $13800.0 in the prior quarter.
  • Over the last five years, Research & Development for STEK hit a ceiling of $13800.0 in Q1 2023 and a floor of $177.0 in Q2 2023.